To see all protocols that comply with the WHO Essential Medicine List 
This fact sheet contains general information about Neurofibromatosis type 1. Each person should be referred to a genetic service for further information and advice.

Key Points

  • People with NF1 have an increased chance of developing benign (non-cancerous) nerve tumours (neurofibromas).
  • People with NF1 have an increased chance of developing both benign and malignant (cancerous) tumours of the brain, spinal cord and nerves behind the eye.
  • Women with NF1 have an increased chance of developing breast cancer.
  • Family members (including children) can be referred to a genetic service where experts can provide information, advice and support about their chance of developing cancer and the option of genetic testing.

This cancer genetics fact sheet is a guide only and cannot cover every possible situation. The information provided is not intended to replace discussion with a health professional, and should not be interpreted as medical advice. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information sources. Use of this document is subject to eviQ's disclaimer available at  www.eviQ.org.au  

Send feedback for this page


First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

https://www.eviq.org.au/p/3449

28 Oct 2021